ARID1A loss induces epithelial–mesenchymal transition in pancreatic ductal adenocarcinoma (PDAC) cell lines, with reduced expression of E-cadherin, increased expression of vimentin, enhanced invasive properties, and upregulation of EMT genes [103,105]. The gene discussed is ARID1A; the disease is pancreatic ductal adenocarcinoma.